These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 20116285

  • 1. Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas.
    Yoon JH, Lee EJ, Cha SS, Han SS, Choi SJ, Juhn JR, Kim MH, Lee YJ, Park SJ.
    J Vasc Interv Radiol; 2010 Mar; 21(3):348-56. PubMed ID: 20116285
    [Abstract] [Full Text] [Related]

  • 2. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY, Lee JM, Shin CI, Lee DH, Moon SK, Kim KW, Han JK, Choi BI.
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [Abstract] [Full Text] [Related]

  • 3. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.
    Kim SH, Kim SH, Lee J, Kim MJ, Jeon YH, Park Y, Choi D, Lee WJ, Lim HK.
    AJR Am J Roentgenol; 2009 Jun; 192(6):1675-81. PubMed ID: 19457834
    [Abstract] [Full Text] [Related]

  • 4. Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging.
    Haradome H, Grazioli L, Tinti R, Morone M, Motosugi U, Sano K, Ichikawa T, Kwee TC, Colagrande S.
    J Magn Reson Imaging; 2011 Jul; 34(1):69-78. PubMed ID: 21598343
    [Abstract] [Full Text] [Related]

  • 5. Gadoxetic acid-enhanced MRI versus multiphase multidetector row computed tomography for evaluating the viable tumor of hepatocellular carcinomas treated with image-guided tumor therapy.
    Hwang J, Kim SH, Kim YS, Lee MW, Woo JY, Lee WJ, Lim HK.
    J Magn Reson Imaging; 2010 Sep; 32(3):629-38. PubMed ID: 20815061
    [Abstract] [Full Text] [Related]

  • 6. Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.
    Yu MH, Kim JH, Yoon JH, Kim HC, Chung JW, Han JK, Choi BI.
    Radiology; 2014 Jun; 271(3):748-60. PubMed ID: 24588677
    [Abstract] [Full Text] [Related]

  • 7. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Muhi A, Araki T.
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
    Lee DH, Lee JM, Baek JH, Shin CI, Han JK, Choi BI.
    Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
    [Abstract] [Full Text] [Related]

  • 9. Comparison of computed tomography versus magnetic resonance imaging in assessing radiofrequency ablation margins after radiofrequency ablation in patients with hepatocellular carcinomas.
    Qu JR, Liu CC, Zhang HK, Li X, Zhang JW, Luo JP, Shao NN, Zhang SN, Li YL, Li HL.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):480-5. PubMed ID: 23134824
    [Abstract] [Full Text] [Related]

  • 10. Gadoxetic acid-enhanced MRI compared with CT during angiography in the diagnosis of hepatocellular carcinoma.
    Ooka Y, Kanai F, Okabe S, Ueda T, Shimofusa R, Ogasawara S, Chiba T, Sato Y, Yoshikawa M, Yokosuka O.
    Magn Reson Imaging; 2013 Jun; 31(5):748-54. PubMed ID: 23218794
    [Abstract] [Full Text] [Related]

  • 11. Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.
    Ahn SS, Kim MJ, Lim JS, Hong HS, Chung YE, Choi JY.
    Radiology; 2010 May; 255(2):459-66. PubMed ID: 20413759
    [Abstract] [Full Text] [Related]

  • 12. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
    Seo HJ, Kim MJ, Lee JD, Chung WS, Kim YE.
    Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
    [Abstract] [Full Text] [Related]

  • 13. Detectability of hepatocellular carcinoma on gadoxetic acid-enhanced MRI at 3 T in patients with severe liver dysfunction: clinical impact of dual-source parallel radiofrequency excitation.
    Nishie A, Kakihara D, Asayama Y, Ushijima Y, Takayama Y, Fujita N, Shimamoto D, Shirabe K, Hida T, Honda H.
    Clin Radiol; 2015 Mar; 70(3):254-61. PubMed ID: 25522901
    [Abstract] [Full Text] [Related]

  • 14. Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT.
    Marin D, Di Martino M, Guerrisi A, De Filippis G, Rossi M, Ginanni Corradini S, Masciangelo R, Catalano C, Passariello R.
    Radiology; 2009 Apr; 251(1):85-95. PubMed ID: 19332848
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Detection of hepatocellular carcinoma: gadoxetic acid-enhanced 3-dimensional magnetic resonance imaging versus multi-detector row computed tomography.
    Kim YK, Kim CS, Han YM, Kwak HS, Jin GY, Hwang SB, Chung GH, Lee SY, Yu HC.
    J Comput Assist Tomogr; 2009 Apr; 33(6):844-50. PubMed ID: 19940648
    [Abstract] [Full Text] [Related]

  • 17. Hepatocellular carcinoma in patients with chronic liver disease: a comparison of gadoxetic acid-enhanced MRI and multiphasic MDCT.
    Baek CK, Choi JY, Kim KA, Park MS, Lim JS, Chung YE, Kim MJ, Kim KW.
    Clin Radiol; 2012 Feb; 67(2):148-56. PubMed ID: 21920517
    [Abstract] [Full Text] [Related]

  • 18. Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns.
    Park MJ, Kim YK, Lee MW, Lee WJ, Kim YS, Kim SH, Choi D, Rhim H.
    Radiology; 2012 Sep; 264(3):761-70. PubMed ID: 22843769
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.
    Suh YJ, Kim MJ, Choi JY, Park YN, Park MS, Kim KW.
    AJR Am J Roentgenol; 2011 Jul; 197(1):W44-52. PubMed ID: 21700994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.